Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing
Translational Oncology · 2026-09 · 71 · 102857
DOI: 10.1016/j.tranon.2026.102857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2026-09. Verfasst von Mengfei Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, Netherlands; Cancer Center Amsterdam, Im…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Cervical cancer is primarily caused by persistent infection with high-risk human papillomavirus (hrHPV), which alters host RNA expression, including regulatory microRNAs (miRNAs). Because urine is emerging as a convenient biosource for cancer detection, we evaluated the feasibility of urinary miRNAs as non-invasive biomarkers for cervical cancer. We optimized miRNA isolation from whole urine and urine fractions using commercial RNA extraction kits, spike-in controls, and digital nanoplate PCR. Following identification of optimal conditions, IsoSeek small RNA sequencing was performed to profile miRNA expression in urine from women with cervical cancer (n = 20) and age-matched controls (n = 20). Differentially expressed candidates were then analytically confirmed by RT-qPCR. The Norgen RNA isolation kit applied to whole urine provided the most robust miRNA recovery. Sequencing identified significantly altered urinary levels of hsa-miR-143-3p and hsa-miR-204-3p in cervical cancer. The ratio of these miRNAs showed strong discriminatory performance for detecting cervical cancer using IsoSeek (AUC = 0.93) and remained robust after RT-qPCR analysis in the same cohort (AUC = 0.84). These findings support the feasibility of using urinary miRNA profiling for non-invasive biomarker discovery and highlight the hsa-miR-143-3p/hsa-miR-204-3p ratio as a promising candidate marker for cervical cancer detection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.
- Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, Netherlands; You2Yourself B.V., Enschede, Netherlands.
- You2Yourself B.V., Enschede, Netherlands.
- Antoni van Leeuwenhoek/Netherlands Cancer Institute, Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Amsterdam, Netherlands.
- Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands. Electronic address: r.st…
Förderung
- China Scholarship Council
Zitieren
APA
Xu, M., Molina, M. A., Gómez-Martín, C., Dekker, M. M. H. S., Ghasemi, S., de Rooij, J., Pegtel, D. M., van Trommel, N. E., & Steenbergen, R. D. M. (2026). Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing. Translational Oncology, 71, 102857. https://doi.org/10.1016/j.tranon.2026.102857
Vancouver
Xu M, Molina MA, Gómez-Martín C, Dekker MMHS, Ghasemi S, de Rooij J, et al. Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing. Translational Oncology. 2026;71:102857. doi:10.1016/j.tranon.2026.102857
BibTeX
@article{Xu2026,
author = {Xu, Mengfei and Molina, Mariano A and Gómez-Martín, Cristina and Dekker, Maaike M H S and Ghasemi, Saba and de Rooij, Johan and Pegtel, D Michiel and van Trommel, Nienke E and Steenbergen, Renske D M},
title = {Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing},
journal = {Translational Oncology},
year = {2026},
volume = {71},
pages = {102857},
doi = {10.1016/j.tranon.2026.102857}
}
EUVIMED